Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/92209
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Effectiveness, cost effectiveness, acceptability and implementation barriers/facilitators of chronic kidney disease management programs and models of care for Aboriginal and Torres Strait Islander Australians: a mixed methods systematic review protocol
Author: Reilly, R.
Evans, K.
Gomersall, J.
Gorham, G.
Warren, S.
O'Shea, R.
Peters, M.
Brown, A.
Cass, A.
Citation: The JBI Database of Systematic Reviews and Implementation Reports, 2015; 13(4):65-86
Publisher: The Joanna Briggs Institute
Issue Date: 2015
ISSN: 2202-4433
2202-4433
Statement of
Responsibility: 
Rachel Reilly, Katharine Evans, Judith Gomersall, Gillian Gorham, Steven Warren, Rebekah O, Shea, Micah Peters, Alex Brown, Alan Cass
Abstract: Review objectives and questions: The objective of this mixed methods review is to synthesize quantitative, economic and qualitative evidence on chronic kidney disease management programs and models delivered to Aboriginal and Torres Strait Islander Australians. Studies with Indigenous participants from New Zealand and Canada will also be considered because similar persistent patterns of health inequities have arisen in these countries as a result of a shared colonial history, despite vast differences in timing and location. Also, there are geographic and demographic similarities, such as remoteness from health services and poor engagement due to differing language, culture and concepts of health and illness from the dominant culture. These socio-demographic circumstances are associated with higher burdens of chronic disease and poorer health outcomes. The intention of this systematic review is to inform chronic kidney disease program design, practice and service delivery to Aboriginal and Torres Strait Islander populations in Australia. The questions to be addressed in the review are: 1. What is the effectiveness of programs/models in relation to outcomes, including, though not limited to, the management of “indicators to target” such as blood pressure control, the delayed progression of kidney disease/time to dialysis, and quality of life? 2. What are the costs and costs relative to benefits of the programs/models from the perspectives of individual patients and their families, the primary health services that deliver them, tertiary health services and society as a whole? 3. What do patient and provider experiences of programs/models reveal about the acceptability of programs, as well as barriers and enablers of implementation?
Keywords: chronic kidney disease; pre-dialysis; prevention; Aboriginal health
Rights: Copyright status unknown
DOI: 10.11124/jbisrir-2015-1400
Published version: http://dx.doi.org/10.11124/jbisrir-2015-1400
Appears in Collections:Aurora harvest 2
Translational Health Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.